NEUARTIGE GALECTIN-GALACTOSIDHEMMER

European patent · EP2424873 · Deleted

Register entry

Publication number
EP2424873
Application number
EP10770027
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Apr 26, 2010
Published
Mar 7, 2012
Granted
Nov 15, 2017
Deleted
Nov 18, 2021
Reason
Annual fee unpaid
IPC classes
C07H 15/22 (2006.01)
A61K 31/7028 (2006.01)
A61K 31/7056 (2006.01)
A61P 19/02 (2006.01)
A61P 29/00 (2006.01)
A61P 35/00 (2006.01)
C07H 19/056 (2006.01)
C07H 5/06 (2006.01)
Priority
US 173284 P 28.04.2009
PCT application
PCT/SE2010/050458 26.04.2010
PCT publication
WO2010/126435 04.11.2010
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 18, 2021

    Deleted, fee unpaid

    Published in Swissreg on 18.11.2021

  2. Sep 22, 2021

    Transferred

    Owner
    Galecto Biotech AB, Smedsbovägen 10, 225 94 Lund, Sweden → Galecto Biotech AB, Ole Maaløes Vej 3, 2200 Copenhagen N, Denmark

    Published in Swissreg on 22.09.2021

  3. Dec 8, 2017

    Agent entered

    Representative
    MICHELI & CIE SA, 122, Rue de Genève, Case postale 61, 1226 Thônex

    Published in Swissreg on 08.12.2017

  4. Nov 15, 2017

    Granted

    Published in Swissreg on 15.11.2017

Parties

Holder

Galecto Biotech AB

Ole Maaløes Vej 3, 2200 Copenhagen N, DK

Agent

MICHELI & CIE SA

122, Rue de Genève Case postale 61, 1226 Thônex

Inventor

LEFFLER, Hakon

S-222 24 Lund, SE

NILSSON, Ulf J.

S-225 94 Lund, SE

VON WACHENFELDT, Henrik

S-226 42 Lund, SE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.